Atlas Trials

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Clinical trial NCT01136395 · COMPLETED

Trial details

NCT number
NCT01136395
Sponsor
University of Giessen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney TransplantationRituximab (RTx)Living DonorsImmunologyVirus
Start date
2010-01-01
Primary completion
2019-06-18
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.